LFWD
Lifeward Ltd.
LFWD's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over LFWD overall, supported by lower modeled downside and stronger modeled upside.
LFWD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
LFWD's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LFWD PE Valuation
LFWD has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
LFWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LFWD has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LFWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$17.23 | +$20.45 |
| Q1 2026 | -$20.07 | +$16.65 |
| Q4 2025 | -$18.89 | +$21.07 |
| Q3 2025 | -$35.88 | -$9.36 |
| Q2 2025 | -$37.68 | -$4.44 |
| Q1 2025 | -$36.72 | -$2.76 |
| Q4 2024 | -$39.96 | -$8.88 |
| Q3 2024 | -$26.52 | +$3.72 |
LFWD is still losing money, but far less than before: $17.23 per share over the past year, against $364.56 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over LFWD on earnings quality, reporting a profit while its opponent remains loss making.
LFWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +16% |
| Q1 2026 | $3.9M | -22% |
| Q4 2025 | $5.1M | -33% |
| Q3 2025 | $6.2M | +1.1% |
| Q2 2025 | $5.7M | -15% |
| Q1 2025 | $5M | -4.7% |
| Q4 2024 | $7.5M | +9.6% |
| Q3 2024 | $6.1M | +39% |
LFWD's revenue is down over the past year, though its latest quarter was up: $7M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -63% | +52 points |
| Q1 2026 | -264% | -167 points |
| Q4 2025 | -101% | +101 points |
| Q3 2025 | -51% | +1.1 points |
| Q2 2025 | -115% | -48 points |
| Q1 2025 | -96% | +27 points |
| Q4 2024 | -202% | -113 points |
| Q3 2024 | -52% | +129 points |
LFWD's operating margin was −63% last quarter, up 52 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over LFWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over LFWD on profitability, with a higher operating margin.
LFWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6M | -$2.1M |
| Q1 2026 | -$3.7M | +$1.8M |
| Q4 2025 | -$3.6M | +$403K |
| Q2 2025 | -$3.9M | +$1.7M |
| Q1 2025 | -$5.5M | +$2.2M |
| Q4 2024 | -$4M | +$594K |
| Q2 2024 | -$5.6M | -$2.1M |
| Q1 2024 | -$7.7M | -$2.4M |
LFWD has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over LFWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
LFWD Net Leverage
LFWD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
LFWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 22.9 | Neutral |
LFWD's weekly RSI is 39 (neutral) and its Stochastic is 23 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
LFWD PE vs Healthcare Sector
LFWD has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
LFWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 6.4% below |
| 20 week MA | $6.92 | 17% below |
| 50 week MA | $7.03 | 19% below |
| 100 week MA | $10.4 | 45% below |
| 200 week MA | $32.9 | 83% below |
LFWD is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over LFWD on trend strength, trading above more of its moving averages.
LFWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $186.5 | $136.1 | -27% |
| 2021 | $136.1 | $113.4 | -17% |
| 2022 | $113.4 | $65.5 | -42% |
| 2023 | $65.5 | $65.4 | -0.2% |
| 2024 | $65.4 | $24.1 | -63% |
| 2025 | $24.1 | $7.73 | -68% |
| 2026 YTD | $7.73 | $5.72 | -26% |
LFWD has finished every year since 2020 lower, and it's down 26% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over LFWD on returns for 2026, with the stronger performance.